Related Experiment Video
Updated: May 18, 2026
Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
The insect peptide CopA3 inhibits lipopolysaccharide-induced macrophage activation
Hyo Jung Nam1, Ah Reum Oh, Seung Taek Nam
1Department of Life Science, College of Natural Science, Daejin University, Pocheon, Gyeonggido, South Korea.
Abstract:
We recently demonstrated that the insect peptide CopA3 (LLCIALRKK), a disulfide-linked dimeric peptide, exerts antimicrobial and anti-inflammatory activities in a mouse colitis model. Here, we examined whether CopA3 inhibited activation of macrophages by LPS. Exposure of an unseparated mouse peritoneal cell population or isolated peritoneal macrophages to LPS markedly increased secretion of IL-6 and TNF-α; these effects were significantly inhibited by CopA3 treatment. The inhibitory effect of CopA3 was also evident in murine macrophage cell line, RAW 264.7. Western blotting revealed that LPS-induced activation of STAT1 and STAT5 in macrophages was significantly inhibited by CopA3. Inhibition of JAK (STAT1/STAT5 kinase) with AG490 markedly reduced the production of IL-6 and TNF-α in macrophages. Collectively, these observations suggest that CopA3 inhibits macrophage activation by inhibiting activating phosphorylations of the transcription factors, STAT1 and STAT5, and blocking subsequent production of IL-6 and TNF-α and indicate that CopA3 may be useful as an immune-modulating agent.
Insights
The insect peptide CopA3 significantly inhibits macrophage activation by blocking STAT1 and STAT5 phosphorylation, reducing inflammatory cytokine production. This suggests CopA3
Area of Science:
- Immunology
- Molecular Biology
- Pharmacology
Background:
- Insect peptide CopA3 exhibits antimicrobial and anti-inflammatory properties.
- Macrophage activation by lipopolysaccharide (LPS) leads to increased pro-inflammatory cytokine secretion.
Purpose of the Study:
- To investigate the inhibitory effects of CopA3 on LPS-induced macrophage activation.
- To elucidate the molecular mechanisms underlying CopA3's immune-modulating activity.
Main Methods:
- Primary mouse peritoneal cells and RAW 264.7 macrophages were stimulated with LPS.
- CopA3 treatment was assessed for its impact on cytokine secretion (IL-6, TNF-α).
- Western blotting was used to analyze STAT1 and STAT5 phosphorylation; JAK inhibition was also studied.
Main Results:
- CopA3 significantly inhibited LPS-induced secretion of IL-6 and TNF-α in macrophages.
- CopA3 suppressed the activation (phosphorylation) of STAT1 and STAT5 induced by LPS.
- Inhibition of JAK kinase mimicked CopA3's effect on reducing cytokine production.
Conclusions:
- CopA3 inhibits macrophage activation by interfering with STAT1 and STAT5 phosphorylation.
- CopA3 effectively blocks the production of key inflammatory cytokines, IL-6 and TNF-α.
- CopA3 demonstrates potential as a novel immune-modulating agent for inflammatory conditions.
More Related Videos
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
09:22High Throughput Fluorometric Technique for Assessment of Macrophage Phagocytosis and Actin Polymerization
Published on: November 27, 2014